Ballad Health Cancer Care - Kingsport

Summary

Ballad Health Cancer Care - Kingsport is a medical facility located in Kingsport, Tennessee. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Ballad Health Cancer Care - Kingsport is involved with conducting 61 clinical trials across 117 conditions. There are 1 research doctors associated with this hospital, such as Asheesh Shipstone.

Top PIs

Clinical Trials running at Ballad Health Cancer Care - Kingsport

Cancer

Breast Cancer

Lung Cancer

Prostate Cancer

Bladder Cancer

Lymphoma

Breast cancer

Chronic Lymphocytic Leukemia

Urothelial Carcinoma

Non-Small Cell Lung Cancer

Olanzapine vs Megestrol Acetate

for Cancer-Related Anorexia

This trial tests whether olanzapine or megestrol acetate is better at increasing appetite in patients with advanced cancer. These patients often struggle with eating and weight loss. Both medications aim to make them feel hungrier, helping them eat more and gain weight. Megestrol acetate is known for its effectiveness in increasing appetite in patients with cancer.

Recruiting

2 awards

Phase 3

1 criteria

Text-Based Smoking Cessation Program

for Rural Cancer Survivors

This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.

Recruiting

2 awards

Phase 3

Sotorasib + Panitumumab

for Cancer

This phase II ComboMATCH treatment trial tests how well AMG 510 (sotorasib) with or without panitumumab works in treating patients with KRAS G12C mutant solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells. Panitumumab is in a class of medications called monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. Giving combination panitumumab and sotorasib may kill more tumor cells in patients with advanced solid tumors with KRAS G12C mutation.

Recruiting

1 award

Phase 2

6 criteria